Percutaneous transluminal mitral commissurotomy for rheumatic mitral stenosis in a 5-year-old child

Maad Ullah1, Mehboob Sultan, Hajira Akbar

  • 1Department of Pediatric Cardiology, Armed Forces Institute of Cardiology and National Institute of Heart Diseases, Rawalpindi, Pakistan.

Pediatric Cardiology
|February 22, 2012
PubMed

Insights

Percutaneous transluminal mitral commissurotomy (PTMC) successfully treated severe rheumatic mitral stenosis in a young child. This minimally invasive procedure improved valve function and symptoms, offering a surgical alternative.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Background:

  • Rheumatic mitral stenosis (MS) is a significant cause of heart disease in children.
  • Severe MS can lead to heart failure and pulmonary hypertension.
  • Surgical intervention carries risks, especially in very young patients.

Observation:

  • A 5-year-old boy weighing 11 kg presented with severe rheumatic mitral stenosis.
  • The patient underwent percutaneous transluminal mitral commissurotomy (PTMC) using a valvuloplasty balloon.
  • This was the youngest and smallest patient reported to undergo successful PTMC for rheumatic MS.

Findings:

  • Post-PTMC, the mean mitral valve pressure gradient decreased from 22 mmHg to 6 mmHg.
  • Mitral valve area increased from 0.4 cm(2) to 0.8 cm(2) immediately post-procedure.
  • Follow-up revealed further improvement: mitral valve area increased to 1.0 cm(2), pulmonary arterial pressure decreased, and mean gradient was 8 mmHg with trivial regurgitation.

Implications:

  • PTMC is a safe and effective treatment for severe rheumatic MS in pediatric patients.
  • This minimally invasive approach can be a viable alternative to open-heart surgery.
  • Successful PTMC in this young child suggests broader applicability in pediatric populations.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.